about
High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphomaIntegrative gene expression profiling reveals G6PD-mediated resistance to RNA-directed nucleoside analogues in B-cell neoplasmsHigh expression of 5-lipoxygenase in normal and malignant mantle zone B lymphocytes.Stem cell transplantation for mantle cell lymphoma: if, when and how?Candidate genes contributing to the aggressive phenotype of mantle cell lymphoma.Targeting the proteasome in mantle cell lymphoma: a promising therapeutic approach.Primary gastrointestinal tract lymphoma: diagnosis and management of common neoplasms.Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative Group.Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance.Antiproliferative activity of RAD001 (everolimus) as a single agent and combined with other agents in mantle cell lymphoma.Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.Establishment and characterization of a new mantle cell lymphoma cell line M-1.Targeting Wnt pathway in mantle cell lymphoma-initiating cells.High rate and prolonged duration of complete remissions induced by rituximab, methotrexate, doxorubicin, cyclophosphamide, vincristine, ifosfamide, etoposide, cytarabine, and thalidomide (R-MACLO-IVAM-T), a modification of the National Cancer InstitInhibition of the proteasome induces cell cycle arrest and apoptosis in mantle cell lymphoma cells.Low-dose metronomic, multidrug therapy with the PEP-C oral combination chemotherapy regimen for mantle cell lymphoma.Prognostic impact of p27KIP1 expression in cyclin D1 positive lymphoproliferative disorders.
P2860
Q28206624-F34FDDD9-3706-432E-9363-D43E32B3A314Q31077729-768ACD8D-0044-4E8C-8A70-488655764BEBQ33398788-F13C2176-FD61-41E2-9133-AAD562284063Q36188687-3A638851-1648-412B-B9A2-9F4C25F71B9BQ36315020-B3B0B9B1-A48E-41A4-9A10-97B4547B0CDCQ36328428-BA9EDBB1-6430-4C9C-B405-E24457B2186EQ36668251-C13DF0CF-AC97-49BB-B431-497B221CDF13Q38110232-997907F1-086F-46D2-8132-3F6D6ED40EE6Q38132359-A54D1763-81E1-479B-AFD2-5022E32AACD5Q40202733-ABFF07D0-9978-4D51-A9CD-49F1D7AAA6E5Q40341141-D6097BED-12B1-42B0-AFEF-AD3D45B573D4Q40516827-5520AA4C-E7E4-4860-8421-4039ABFB9625Q42558443-6E80A44F-7677-4AFE-BB0E-DB874D8B81B5Q43206359-F3EA3F7F-E68A-4AD2-A21A-205B47BB36C6Q44503964-05F27D76-8377-4909-A248-C44B166249CDQ46735742-85464A6A-A86D-416E-AF08-D52FE1F273BFQ47929697-C6A1E71D-12F5-4464-8EFC-91ED02EDA1D4
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Biology and management of mantle cell lymphoma.
@ast
Biology and management of mantle cell lymphoma.
@en
Biology and management of mantle cell lymphoma.
@nl
type
label
Biology and management of mantle cell lymphoma.
@ast
Biology and management of mantle cell lymphoma.
@en
Biology and management of mantle cell lymphoma.
@nl
prefLabel
Biology and management of mantle cell lymphoma.
@ast
Biology and management of mantle cell lymphoma.
@en
Biology and management of mantle cell lymphoma.
@nl
P2093
P1476
Biology and management of mantle cell lymphoma.
@en
P2093
Leonard JP
Schattner EJ
P304
P356
10.1097/00001622-200109000-00005
P577
2001-09-01T00:00:00Z